Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine for Assessment of Mitral Regurgitation Severity
NCT04500899Phase 2Recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Dec 2020
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phenylephrine in mitral regurgitation (MR), sponsored by Montefiore Medical Center. Started Dec 2020; status: recruiting.
02
Drugs
phenylephrine
03
Conditions
mitral regurgitation (MR)
Beyond the preview
Go deeper on NCT04500899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04500899.